Rising healthcare costs, an aging population, and the COVID-19 pandemic have spurred the rapid expansion of care at home

However, home infusion therapy has yet to fully take shape due to a host of challenges. In a recent survey, CareCentrix interviewed U.S. payors representing Medicare, Commercial, and Medicaid lines of business. The goal was to take a pulse of the marketplace, identify key barriers, and gain insights about the factors shaping the move to home infusion therapy.

Learn what payors revealed about the future of Home Infusion.